Adverse drug reactions to tocolytic treatment for preterm labour: Prospective cohort study

BMJ (Online)

Volumn 338, Issue 7697, 2009, Pages

  De Heus, Roel ^a   Mol, Ben Willem ^b,c   Erwich, Jan Jaap H M ^d   Van Geijn, Herman P ^e   Gyselaers, Wilfried J ^h   Hanssens, Myriam ⁱ   Harmark, Linda ^g   Van Holsbeke, Caroline D ^h   Duvekot, Johannes J ^f   Famschobben, Fred ^a   Wolf, Hans ^c   Visser, Gerard H A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

^h DEPARTMENT OF CARDIOLOGY   (Belgium)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; FENOTEROL; GLYCERYL TRINITRATE; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; RITODRINE; UTERUS SPASMOLYTIC AGENT;

ADULT; ADVERSE DRUG REACTION; ANAPHYLACTIC SHOCK; ARTICLE; BELGIUM; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FETUS; FETUS DEATH; GESTATIONAL AGE; HEADACHE; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; HYPOXIA; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MEMBRANE RUPTURE; NAUSEA; NETHERLANDS; NEWBORN DEATH; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE; SYNCOPE; TACHYCARDIA; TOCOLYSIS; UNSPECIFIED SIDE EFFECT;

EID: 77951731986     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 2006;19:773-82.
2. Hoyert DL, Mathews TJ, Menacker F, Strobino DM, Guyer B. Annual summary of vital statistics: 2004. Pediatrics 2006;117:168-83.
3. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000(2):CD000065.
4. KingJF, FlenadyVJ, Papatsonis DN, DekkerGA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003(1):CD002255.
5. KingJ, FlenadyV, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005(2):CD001992.
6. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004(4):CD004352.
7. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Br J Obstet Gynaecol 2001;108:133-42.
8. French/Australian Atosiban Investigators Group. Treatment of preterm labourwith the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177-85.
9. Coomarasamy A, Knox EM, Gee H, Khan KS. Oxytocin antagonists for tocolysis in preterm labour-asystematic review. Med Sci Monit 2002;8:RA268-73.
10. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol 1994;170(1 Pt1):102-6.
11. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications afterthe administration ofindomethacin forpreterm labour. N EnglJMed 1993;329:1602-7.
12. Papatsonis DN, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management ofpreterm labour: a randomized multicentertrial. ObstetGynecol 1997;90:230-4.
13. Van Geijn HP, LengletJE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. Br J Obstet Gynaecol 2005;112(suppl 1):79-83.
14. Oei SG. Calcium channel blockers for tocolysis: a review oftheirrole and safety following reports of serious adverse events. Eur J Obstet Gynecol Reprod Biol 2006;126:137-45.
15. Simhan HN, Caritis SN. Prevention of preterm delivery. NEnglJMed 2007;357:477-87.
16. Rosen LJ, Zucker D, Oppenheimer-GazitV, Yagel S.The great tocolytic debate: some pitfalls in the study of safety. Am J Obstet Gynecol 2001;184:1-7.
17. VenuletJ, BankowskiZ. Harmonising adverse drugreaction terminology: the role ofthe Council forInternational Organizationsof Medical Sciences. Drug Saf1998;19:165-72.
18. Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf1997;17:374-89.
19. OeiSG, OeiSK, Brolmann HA. Myocardial infarction duringnifedipine therapy for preterm labour. NEnglJ Med 1999;340:154.
20. Verhaert D, Van Acker R. Acute myocardial infarction during pregnancy. Acta Cardiol 2004;59:331-9.
21. Nassar AH, Ghazeeri G, Usta IM. Nifedipine-associated pulmonary complications in pregnancy. IntJ Gynaecol Obstet 2007;97:148-9.
22. Abbas OM, Nassar AH, KanjNA, Usta IM. Acute pulmonary oedema during tocolytic therapy with nifedipine. Am J Obstet Gynecol 2006;195:e3-4.
23. Papatsonis DN, Bos JM, van Geijn HP, LokCA, DekkerGA. Nifedipine pharmacokinetics and plasma levels in the management of preterm labour. Am J Ther 2007;14:346-50.
24. VanVeen AJ,Pelinck MJ,vanPampusMG,ErwichJJ. Severe hypotension and fetal death due to tocolysis with nifedipine. Br J ObstetGynaecol 2005;112:509-10.
25. Harake B, Gilbert RD, AshwalS, PowerGG. Nifedipine: effects on fetal and maternal hemodynamics in pregnantsheep. Am J Obstet Gynecol 1987;157(4 Pt 1):1003-8.
26. Blea CW, Barnard JM, Magness RR, Phernetton TM, Hendricks SK. Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe. Am J Obstet Gynecol 1997;176:922-30.
27. Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, Provost-Helou N, Ducloy-Bouthors AS, Puech F, et al. Acute pulmonary oedema during nicardipine therapy for premature labour; report of five cases. Eur J ObstetGynecol Reprod Biol 2004;113:98-9.
28. Hodges R, Barkehall-Thomas A, Tippett C. Maternal hypoxia associated with nifedipine for threatened preterm labour. BrJObstet Gynaecol 2004;111:380-1.
29. Coomarasamy A, Knox EM, Gee H, Song F, Khan KS. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a metaanalysis with an indirect comparison of randomised trials. Br J Obstet Gynaecol 2003;110:1045-9.